The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
[18F]NaF PET/CT imaging biomarkers of progression-free survival in metastatic prostate cancer.
 
Stephanie Harmon
No Relationships to Disclose
 
Tim Perk
No Relationships to Disclose
 
Jens C. Eickhoff
No Relationships to Disclose
 
Mary Jane Staab
No Relationships to Disclose
 
Peter L. Choyke
No Relationships to Disclose
 
William L. Dahut
No Relationships to Disclose
 
Andrea B. Apolo
No Relationships to Disclose
 
John Humm
No Relationships to Disclose
 
Steven M. Larson
No Relationships to Disclose
 
Michael J. Morris
Consulting or Advisory Role - Astellas Pharma; Bayer; Millennium; Progenics
Research Funding - Agensys (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - fujifilm
 
Scott Perlman
No Relationships to Disclose
 
Glenn Liu
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - Cellectar (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
Other Relationship - AIQ Solutions
 
Robert Jeraj
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
Other Relationship - AIQ Solutions